Urinary soluble CD163 level reflects glomerular inflammation in human lupus nephritis-Reference-Cited by-同舟云学术

Urinary soluble CD163 level reflects glomerular inflammation in human lupus nephritis

Published:2016-05-30 Issue:12 Volume:31 Page:2023-2033
ISSN:0931-0509
Container-title:Nephrology Dialysis Transplantation
language:en
Short-container-title:Nephrol. Dial. Transplant.

Author:

Endo Nobuhide,Tsuboi Naotake,Furuhashi Kazuhiro,Shi Yiqin,Du Qiuna,Abe Tomoko,Hori Mayuko,Imaizumi Takahiro,Kim Hangsoo,Katsuno Takayuki,Ozaki Takenori,Kosugi Tomoki,Matsuo Seiichi,Maruyama Shoichi

Publisher

Oxford University Press (OUP)

Subject

Transplantation,Nephrology

Link

http://academic.oup.com/ndt/article-pdf/31/12/2023/17109495/gfw214.pdf

Reference48 articles.

1. Macrophages in Renal Disease

2. Protective and pathogenic functions of macrophage subsets

3. Renal microenvironments and macrophage phenotypes determine progression or resolution of renal inflammation and fibrosis

4. Ex vivo programmed macrophages ameliorate experimental chronic inflammatory renal disease

5. Transfused macrophages ameliorate pancreatic and renal injury in murine diabetes mellitus;Zheng;Nephron Exp Nephrol,2011

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Urinary soluble CD163 is useful as “liquid biopsy” marker in lupus nephritis at both diagnosis and follow-up to predict impending flares;Journal of Translational Autoimmunity;2024-12

2. Clinical significance of serum soluble scavenger receptor CD163 in patients with lupus nephritis;Lupus;2024-08-22

3. Investigating the value of urinary biomarkers in relation to lupus nephritis histopathology: present insights and future prospects;Frontiers in Pharmacology;2024-07-22

4. Non-invasive biomarkers of disease activity and organ damage in ANCA-associated vasculitis: a systematic review;RMD Open;2024-02

5. Proximity extension assay proteomics and renal single cell transcriptomics uncover novel urinary biomarkers for active lupus nephritis;Journal of Autoimmunity;2024-02